RecruitingPhase 1NCT06920238

Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

A Phase I Single-Arm Trial to Test the Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use Disorder (CUD)


Sponsor

Trustees of Dartmouth College

Enrollment

15 participants

Start Date

Apr 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if Therabot-CALM (Cannabis, Anxiety, Low Mood) has acceptability among users and could work to improve the symptoms of persons with cannabis use disorder and anxiety and/or depression. The main question it aims to answer is: What is the usability, feasibility, and acceptability of Therabot-CALM in persons with Cannabis Use Disorder and Anxiety and/or Depression? Participants will * Take a screening questionnaire * Participate in two virtual 1-hour interviews to provide feedback on app design and suggest features. * Engage with Therabot-CALM in a 4-week clinical trial and provide feedback on their app experience in a third virtual interview


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a generative AI chatbot called Therabot-CALM can help reduce anxiety and depression in people who also use cannabis heavily. The goal is to find a digital mental health tool that can reach people who may not otherwise access therapy. **You may be eligible if...** - You are 18 or older - You meet the criteria for cannabis use disorder AND moderate-to-severe depression and/or anxiety - You have reliable internet access and a compatible device - You are willing to attend a first interview and complete all study assessments **You may NOT be eligible if...** - You are at moderate-to-high risk of suicide or self-harm - You are currently experiencing psychosis - You are already participating in another digital mental health program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETherabot-CALM

Therabot is a generative-AI-driven mobile app designed to provide mental health treatment. The feasibility of Therabot-CALM, an adapted Therabot application, is being tested for the future use of treating co-occurring substance use disorders and anxiety and/or depression. The primary purpose of this study is application feasibility.


Locations(1)

46 Centerra Parkway, Suite 300, Office #333S

Lebanon, New Hampshire, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06920238


Related Trials